Drug Trial Radar · NCT01291511
Relapse Prevention Study in Patients With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Jul 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
635
Actual
Start
Feb 2011
Primary completion
Mar 2014
Study completion Mar 2015
Sponsor
- Lead sponsor
- Vanda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Feb 8, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Iloperidone is effective in the prevention of relapse in patients with schizophrenia
Conditions
- Schizophrenia
Interventions
IloperidoneDrug
Over-encapsulated iloperidone tablets were administered orally using a bid schedule; the strengths used include 1, 2, 4, 6, 8, 10, and 12 mg.
PlaceboDrug
Matching placebo capsules were administered orally using a bid schedule during the double-blind period.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Relapse or Impending RelapseTime frame: Up to 26 weeks post-randomization
Locations
63 sites in 3 countries. Site status is shown where the registry gives one.
Vanda Investigative Site
Anaheim, California
Vanda Investigative Site
Bellflower, California
Vanda Investigative Site
Costa Mesa, California
Vanda Investigative Site
Escondido, California
Vanda Investigative Site
La Habra, California
Vanda Investigative Site
Oceanside, California
Vanda Investigative Site
Orange, California
Vanda Investigative Site
Pico Rivera, California
Vanda Investigative Site
Riverside, California
Vanda Investigative Site
San Diego, California
Vanda Investigative Site
San Diego, California
Vanda Investigative Site
San Diego, California
Vanda Investigative Site
Santa Ana, California
Vanda Investigative Site
Melbourne, Florida
Vanda Investigative Site
Miami, Florida
Vanda Investigative Site
Oakland Park, Florida
Vanda Investigative Site
Atlanta, Georgia
Vanda Investigative Site
Atlanta, Georgia
Vanda Investigative Site
St Louis, Missouri
Vanda Investigative Site
Nashua, New Hampshire
Vanda Investigative Site
Marlton, New Jersey
Vanda Investigative Site
Brooklyn, New York
Vanda Investigative Site
Staten Island, New York
Vanda Investigative Site
Hickory, North Carolina
Vanda Investigative Site
Beachwood, Ohio
Vanda Investigative Site
Philadelphia, Pennsylvania
Vanda Investigative Site
Irving, Texas
Vanda Investigative Site
Salt Lake City, Utah
Vanda Investigative Site
Ahmedabad, Gujarat, India
Vanda Investigative Site
Madhava Nagar, Karnataka, India
Vanda Investigative Site
Mangalore, Karnataka, India
Vanda Investigative Site
Mangalore, Karnataka, India
Vanda Investigative Site
Mysore, Karnataka, India
Vanda Investigative Site
Nashik, Maharashtra, India
Vanda Investigative Site
Pune, Maharashtra, India
Vanda Investigative Site
Jaipur, Rajasthan, India
Vanda Investigative Site
Madurai, Tamil Nadu, India
Vanda Investigative Site
Kanpur, Uttar Pradesh, India
Vanda Investigative Site
Lucknow, Uttar Pradesh, India
Vanda Investigative Site
Lucknow, Uttar Pradesh, India
Showing 40 of 63 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.